Search Contract Opportunities

ID/IQ for Regulatory Consultant, Non-Personal Services   5

ID: W911QY20R0007 • Type: Synopsis Solicitation
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: March 31, 2021, 2:04 p.m. EDT

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6 supplemented by FAR Subpart 13.5 with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation will not be issued. The solicitation number is W911QY21R0007 and is issued as a Request for Proposal (RFP), unless otherwise indicated herein. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-09. The associated North American Industrial Classification System (NAICS) code for this procurement is 541714 with a small business size standard of 1,000 employees. This requirement is being solicited using full and open competition. Both small and other than small businesses may respond.

The Government requires the ability to engage senior regulatory experts to provide consultation and reporting on projects related to FDA regulations, quality auditing, FDA package submissions and other task areas. Please see the attached solicitation document and related attachments for the Performance Work Statement, ID/IQ CLIN schedule, response requirements, evaluation criteria and all terms and conditions.

All contractors must be actively registered in the System for Award Management without exclusions to be eligible for award.

The Contractor shall not be reimbursed for any costs incurred prior to the effective date of the contract.

Information contained in the successful or unsuccessful Offeror's Management or Price proposal must be released under the Freedom of Information Act (5 U.S.C. 552) upon request from the public after contract award, except to the extent it contains trade secrets and privileged or confidential commercial or financial information. If the Offeror's proposal contains material meeting this description which is customarily maintained in confidence in the course of the Offeror's business and is not otherwise publicly available, and if the Offeror does maintain this information in confidence and it is not otherwise publicly available, and if the Offeror does not want it disclosed to the public, the title page shall be marked with the legend that follows.

"This proposal, furnished in response to Solicitation No. W911QY-21-R-0007 contains trade secrets and/or privileged or confidential commercial or financial information. This information is maintained in confidence in the course of the Offeror's business and is not otherwise publicly available. The Offeror submits this information to the Government in confidence and understands that it is received with that intent. This information shall not be released or disclosed outside the Government under the Freedom of Information Act (5 U.S.C. 552) or under any other circumstances."

Proposals so marked will be accepted by the Government in confidence and will not be released provided that the Offeror and/or the Government can show, upon request under the Freedom of Information Act, that disclosure would either (1) impair the Government's ability to obtain necessary information in the future or (2) cause substantial harm to the competitive position of the Offeror.

Responses shall be submitted electronically to scott.i.hoffman2.civ@mail.mil, no later than the time and date specified in this notice. A courtesy copy shall be provided to susan.e.ruzicka2.civ@mail.mil no later than the time and date specified in this notice.

Questions regarding this solicitation shall be sent to scott.i.hoffman2.civ@mail.mil and a courtesy copy provided to susan.e.ruzicka2.civ@mail.mil, no later than 11:00 am Eastern time on 30 November 2020.

**Amendment 0001***

Amendment 0001 to this solicitation has been issued to extend the due date for responses from 07 December 2020 to 18 December 2020. See attachment for additional information.

***Amendment 0002***

Amendment 0002 to this solicitation has been issued to post responses to contractor questions, revise the terms of the solicitation, revise solicitation Attachments A and D and extend the due date for responses from 18 December 2020 to 28 December 2020. See attachments for additional information.

Posted: March 31, 2021, 2:04 p.m. EDT
Posted: Dec. 16, 2020, 2:21 p.m. EST
Posted: Dec. 3, 2020, 12:17 p.m. EST
Posted: Nov. 23, 2020, 11:19 a.m. EST
Background
The JPEO-CBRND’s mission is to provide Research, Development, Acquisition Fielding and Life-Cycle Support of Chemical, Biological, Radiological and Nuclear Defense Equipment, Medical Counter Measures (MCM) and Installation and Force Protection Integrated Capabilities Supporting the National Strategies. The rBV A/B investigational vaccine and plague (rF1V) investigational vaccine are developed by DVC, and are intended for protection of the Joint Forces from exposure or potential exposure to Botulinum neurotoxins (BoNTs) serotypes A and B and pneumonic plague, respectively. Both vaccines have completed Phase 2 clinical trials. Prior to initiating Phase 3 clinical trials, both vaccines underwent Drug Product manufacturing changes to reduce particulates. There is a need for regulatory and cGMP manufacturing expertise to provide consultation/interpretation and evaluation of the DVC pre-EUA draft packages for emergency use of the new Drug Products of rBV A/B and plague vaccines to ensure the regulatory approach taken will meet legal and regulatory requirements for emergency use during a military emergency per the Federal Food, Drug and Cosmetics Act (FFDCA) and PL 115-92, and as outlined in the Emergency Use Authorization guidance document.

The contractor is required to provide expertise in identifying appropriate Subject Matter Experts to conduct the regulatory and quality risk assessment. This includes attending a kick-off meeting with JPEO-CBRND to discuss the purpose and scope of the assessment, executing a review of materials, providing written comments and a report identifying actual or potential regulatory risks and risk mitigation strategies, requesting additional information or clarification as needed, scheduling periodic meetings with the Senior Director Medical Regulatory and ONE-RAQA to discuss task progress, performing a site visit to DVC’s Drug Products manufacturer for an in-depth review of manufacturing changes and batch record review of newly manufactured Drug Products, participating in a meeting with the JPEO-CBRND team to discuss details of their report and provide recommendations to the Senior Director Medical Regulatory, finalizing the report after this meeting, providing monthly execution reports specific to this task during the period of performance.

Overview

Response Deadline
Dec. 28, 2020, 11:00 a.m. EST (original: Dec. 7, 2020, 11:00 a.m. EST) Past Due
Posted
Nov. 23, 2020, 11:19 a.m. EST (updated: March 31, 2021, 2:04 p.m. EDT)
Set Aside
None
Place of Performance
Not Provided
Source
SAM

Current SBA Size Standard
1000 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 11/23/20 ACC Aberdeen Proving Ground issued Synopsis Solicitation W911QY20R0007 for ID/IQ for Regulatory Consultant, Non-Personal Services due 12/28/20. The opportunity was issued full & open with NAICS 541714 and PSC AN15.
Primary Contact
Name
Scott I. Hoffman   Profile
Phone
(301) 619-8148

Secondary Contact

Name
Susan E. Ruzicka   Profile
Phone
(301) 619-8802

Documents

Posted documents for Synopsis Solicitation W911QY20R0007

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Synopsis Solicitation W911QY20R0007

Award Notifications

Agency published notification of awards for Synopsis Solicitation W911QY20R0007

IDV Awards

Indefinite delivery vehicles awarded through Synopsis Solicitation W911QY20R0007

Contract Awards

Prime contracts awarded through Synopsis Solicitation W911QY20R0007

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation W911QY20R0007

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation W911QY20R0007

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEPT OF THE ARMY > AMC > ACC > ACC-CTRS > ACC-APG
FPDS Organization Code
2100-W911QY
Source Organization Code
500038649
Last Updated
April 1, 2021
Last Updated By
PI33_DR_IAE_51681
Archive Date
April 10, 2021